FDA Inspection 932525 — Strides Pharma, Inc.

Strides Pharma, Inc. — FEI 2434223

The FDA completed an inspection of Strides Pharma, Inc. on June 4, 2015 in Chestnut Ridge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 4, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chestnut Ridge, NY (United States)